Lastest news
Honouring Morag Park, PhD, for her tenure as GCI Director
On September 18, 2025, the Rosalind and Morris Goodman Cancer Institute proudly celebrated Professor Morag Park for her exceptional leadership. Colleagues, supporters, and friends came together to honour her remarkable 12-year legacy as Director of the GCI.
The
knowledge
to cure
Rosalind & Morris Goodman Institute
We bring together some of the brightest minds in cancer research who uncover game-changing knowledge to help tackle cancer faster and more effectively.
Our researchers Our core facilities Our networks
The quest to overcome cancer
Our training programs
Eager to start your career in cancer research? Your journey starts here! By training at our Institute, you will be mentored by world leading researchers who are passionate about training the next generation of leaders.
A rewarding career awaits
Bring your passion and advance your career. Join our team driven by collaboration and a determination to make a difference for cancer patients.
Events
GCI Frontiers in Cancer Research Lecture Series
Sep 24, 2026
Montreal
"Tissue protective effects of oncogenic p53 mutation in a mouse model" Yinon Ben-Neriah, MD-PhD, Professor of immunology and cancer research at the Hebrew University of Jerusalem
GCI Frontiers in Cancer Research Lecture Series
Sep 30, 2026
Montreal
"Mapping non-canonical neutrophils lineages in cancer" Dr. Daniela Cerezo-Wallis, Associate Research Scientist, Yale School of Medicine, USA
GCI Frontiers in Cancer Research Lecture Series
Oct 14, 2026
Montreal
"Identifying and targeting MYC protein-protein interactions" Linda Z. Penn, Ph.D., Canadian Research Chair in Molecular Oncology (Tier 1), UHN Director, Office of Research Trainees (ORT), Senior Scientist, Princess Margaret Cancer Centre, University Health Network,Professor, Department of Medical Biophysics, University of Toronto
GCI Frontiers in Cancer Research Lecture Series
Oct 30, 2026
Montreal
"Decoding Aneuploidies - using CRISPR technologies in mice to unravel novel cancer driver genes and vulnerabilities in recurrent CAN" Dr. Daniel Schramek, Senior Investigator and the Deputy Director at the Lunenfeld-Tanenbaum Research Institute/Mount Sinai Hospital in Toronto, and a Professor at the Department of Molecular Genetics, Temerty Faculty of Medicine
Finding knowledge that changes the outcome for cancer patients starts with you!
Groundbreaking research happens here every day. These great discoveries are not made by researchers alone. We rely on the support of our community to empower our scientists in bringing forward bold solutions to overcome cancer.
Rosalind & Morris Goodman Cancer Institute all rights reserved • Privacy policy • Accessibility
Website by Riposte
